Prevalence of type 2 diabetes mellitus by nationality in publicly funded primary health settings
| NCD | Nationality | 18–29 years | 30–39 years | 40–49 years | 50–59 years | ≥60 years | N | Crude rate (/1000) | Age-adjusted rate (/1000) * | |
| Type 2 diabetes mellitus | Qatari | 22.52 | 68.03 | 198.2 | 424.92 | 642.97 | 21 248 | 197.28 | 230.4 | |
| Non-Qatari | Northern Africa | 14.18 | 53.72 | 170.67 | 359.96 | 495.68 | 9999 | 139.66 | 184.95 | |
| Sub-Saharan Africa | 7.76 | 27.89 | 123.01 | 252.62 | 388.89 | 662 | 67.58 | 134.78 | ||
| Latin America and the Caribbean | 0 | 15.04 | 55.56 | 112.68 | (200) | 21 | 54.83 | (64.44) | ||
| Northern America | 8.53 | 13.61 | 72.54 | 207.48 | 340.06 | 292 | 120.46 | 107.68 | ||
| Eastern and Central Asia | 0 | 17.24 | 34.09 | (108.11) | (95.24) | 12 | 25.37 | (42.1) | ||
| South-Eastern Asia | 5.95 | 17.44 | 68.98 | 208.52 | 354.2 | 1946 | 53.53 | 109.72 | ||
| Southern Asia | 10.76 | 61.75 | 211.02 | 434.19 | 587.2 | 22 263 | 173.91 | 219.72 | ||
| Western Asia (excluding Qatar) | 14.62 | 40.82 | 144.17 | 329.8 | 526.69 | 8113 | 135.92 | 178.48 | ||
| Eastern Europe | 0 | 0 | 28.57 | 132.08 | (210.53) | 19 | 28.02 | (60.89) | ||
| Northern Europe | 16.81 | 20.68 | 54.09 | 124.15 | 216.08 | 155 | 65.68 | 74.59 | ||
| Southern Europe | 6.85 | 3.38 | 12.77 | 93.22 | (46.51) | 18 | 21.48 | (26.54) | ||
| Western Europe | 13.16 | 17.75 | 62.5 | 90 | (222.22) | 34 | 60.07 | (70.63) | ||
| Australasia | 0 | 24.39 | 29.13 | 132.08 | (395.35) | 36 | 92.54 | (98.34) | ||
| Non-Qatari (Total) | 11.87 | 47.83 | 164.17 | 365.48 | 528.39 | 43 570 | 138.95 | 188.3 | ||
*Figures (rates) enclosed within parentheses were based (or one of its components) on <50 unweighted observations.